Finzati - Logo
GDRX logo

GoodRx Holdings, Inc.

GDRX • Medical - Healthcare Information Services
$3.48
▼ -0.05 (-1.42%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.21B
Growth
27.1%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 5.3%Positive free cash flow · 0.46Consistent free cash flow · 5/5Manageable debt level · 0.1Healthy liquidity · 2.61
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:11 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$3.48
Change-1.42%
Shares Out348.06M
Market Cap$1.21B
Enterprise Value$1.40B
52W Range1.77 - 5.81
Beta1.61
P/E74.54
P/S1.54
P/B1.87
P/FCF7.01
EV/Sales1.79

Investment DNA

How strong this company looks for long-term investors

69
out of 100
Business Quality
Margins, moat, returns
52/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
74/100
Price Attractiveness
Cheap or expensive today
81/100
Why this score▼
Positive revenue growth · 5.3%Positive free cash flow · 0.46Consistent free cash flow · 5/5Manageable debt level · 0.1Healthy liquidity · 2.61

Analyst view

Analyst sentiment and price target

GDRX
Analyst sentiment
Based on 24 analyst votes · 2026-09-05
65/100
Neutral
Bullish
9
Hold
13
Bearish
2
Price Target
2026-08-07
Low
$4.00
Mean
$4.50
Median
$4.50
High
$5.00

Company Overview

IPO: 9/23/2020
Industry: Medical - Healthcare Information Services
P/B i: 1.87
Debt / Equity i: 0.10
Operating Margin: 10.98%
Net Margin: 3.82%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.10
Current Ratio: 2.61
Quick Ratio: 2.61
Status: Good

Insider Transactions

Recent executive and insider activity

Chan Thomas (TC)
Transaction: 07/15/2026
SELL
Change
-2,947
Price
$3.01
Filing
07/16/2026
Type
SELL
Chan Thomas (TC)
Transaction: 07/15/2026
SELL
Change
-5,792
Price
Not reported
Filing
07/16/2026
Type
SELL
Barnes Wendy Lynn
Transaction: 07/15/2026
SELL
Change
-50,021
Price
$3.01
Filing
07/16/2026
Type
SELL